Weekly: Trillium Therapeutics sinks 5.8% on robust volume September 21, 2018 17:00 EDT
CANADIAN WEEKLY STOCK REPORT
Trillium Therapeutics Inc. (TSX:TRIL), Canada's 17th largest Biotechnology company by market cap, has dropped 48.0c (or 5.8%) in the past week to close at CAD7.79. Compared with the S&P/TSX 60 Index which rose 14.9 points (or 1.6%) in the week, this represented a relative price change of -7.2%. This has been exacerbated by robust volume of 1.6 times average for the week. In the past week the market cap has declined CAD6.9 million (US$5.4 million).